Skip to main content
FDA approves tezepelumab-ekko (Tezspire) for severe asthma
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves tezepelumab-ekko (Tezspire) for severe asthma
User login
Username
Password
Reset your password
Concept
Lead
score
Severe Asthma
1
1
Asthma
0
0.99
Pregnancy
0
0.7
Allergy
0
0.34
Bronchospasm
0
0.34
Lung
0
0.34
Monoclonal Antibody
0
0.34
Otolaryngology
0
0.34
Status Asthmaticus
0
0.34
Arthralgia
0
0.29
Quality of Life
0
0.29
Allergic Conjunctivitis
0
0.24
Ocular Allergy
0
0.19
Biologic Therapy
0
0.17
Child
0
0.98
Clinical Research
0
0.17
Conjunctivitis
0
0.17
Cytokines
0
0.17
Dorsum
0
0.17
Food and Drug Administration (FDA)
0
0.97
Hospital
0
0.17
Pain
0
0.17
Pathogenesis
0
0.17
Pharyngitis
0
0.17
Thymus
0
0.17
Pain Management
0
0.16
Back Pain
0
0.09
Cornea and External Disease
0
0.07
Vaccines
0
0.07
Specialty
Lead
score
Pulmonary Medicine
1
1
Family Medicine/Primary Care
0
0.9
Internal Medicine
0
0.8